The Russian company R-Pharm, which produces the Sputnik V vaccine, plans to start drug production in Germany in the summer of 2021, TASS reports citing the DPA agency.
According to the German agency, production can be deployed in June or July at a plant in the Bavarian city of Illertissen.
“We are making every effort to ensure that production starts in the summer. We already have equipment and personnel there… We expect the decision of the European Medicines Agency (EMA), because it will be the legal basis on which we can start production, “Alexander Bykov, Director of Health Economics, said in an interview with DPA.
EMA on March 4 announced the start of a sequential examination procedure for the Sputnik V vaccine. It is expected that the process will be completed by mid-May, after which the developers will be able to apply for a registration certificate. Russian Minister of Health Mikhail Murashko said that a group of EMA experts will come to Russia on April 10 to control the tests of the Russian vaccine.
